A 31 year old Haitian female presented with acute worsening of chronic diarrhea and weight loss of one year duration. CT of the abdomen showed diffuse mesenteric, pelvic and groin lymphadenopathy. HTLV-1 serology was positive and patient was diagnosed with adult T cell leukemia (ATL) by bone marrow biopsy and flow cytometry. Stool *Clostridium difficile* (*C. difficile*) PCR was positive and oral vancomycin was started. Although patient denied any recent antimicrobial exposure, a partial response to treatment suggested that *C. difficile* was not a colonizer. However after 7 days of treatment the patient continued having more than 10 episodes of watery diarrhea per day. Stool for ova and parasites were initially negative, but subsequent 3 specimens were found to be positive for *Cystoisospora belli* ([Fig. 1](#fig0005){ref-type="fig"}). The patient was started on oral trimethoprim/sulfamethoxazole (TMP/SMX) BID and within 2 days the diarrhea resolved. The patient completed 10 days of treatment. Chemotherapy was initiated and after completing the second cycle patient was discharged.Fig. 1Isospora image.Fig. 1

Two months after discharge the patient presented again with worsening diarrhea for 2 days. Stool was negative for *C. difficile* but was positive again for *Cystoisospora belli*. Patient was restarted on TMP/SMX. Symptoms resolved completely within a day. The patient was discharged on TMP/SMX prophylaxis 3 times / week as a secondary prophylaxis for Cystoisosporiasis.

To our knowledge this case is the first case of a patient with HTLV1 associated leukemia who presented with *C. difficile* colitis and *Cystoisospora belli* infection. This case highlights the importance of looking for co-pathogen especially in patients who are immunocompromised who do not respond to treatment of *C. difficile* colitis. The case raises a question about the need for secondary prophylaxis after an initial episode of infection with *Cystoisospora belli* in patients with HTLV-1 associated leukemia as these patients are likely to have a recurrence without continuous antimicrobial prophylaxis.
